639 related articles for article (PubMed ID: 19608208)
1. Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats.
Boor P; Celec P; Behuliak M; Grancic P; Kebis A; Kukan M; Pronayová N; Liptaj T; Ostendorf T; Sebeková K
Metabolism; 2009 Nov; 58(11):1669-77. PubMed ID: 19608208
[TBL] [Abstract][Full Text] [Related]
2. Aerobic training and diabetic nephropathy in the obese Zucker rat.
Ward KM; Mahan JD; Sherman WM
Ann Clin Lab Sci; 1994; 24(3):266-77. PubMed ID: 8048799
[TBL] [Abstract][Full Text] [Related]
3. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
Nakamura S; Tachikawa T; Tobita K; Aoyama I; Takayama F; Enomoto A; Niwa T
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S68-71. PubMed ID: 12612956
[TBL] [Abstract][Full Text] [Related]
4. Renal effects of S18886 (Terutroban), a TP receptor antagonist, in an experimental model of type 2 diabetes.
Sebeková K; Eifert T; Klassen A; Heidland A; Amann K
Diabetes; 2007 Apr; 56(4):968-74. PubMed ID: 17267764
[TBL] [Abstract][Full Text] [Related]
5. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
Blanco S; Vaquero M; Gómez-Guerrero C; López D; Egido J; Romero R
Am J Hypertens; 2005 Apr; 18(4 Pt 1):557-65. PubMed ID: 15831368
[TBL] [Abstract][Full Text] [Related]
6. Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats.
Soulis T; Cooper ME; Sastra S; Thallas V; Panagiotopoulos S; Bjerrum OJ; Jerums G
Diabetologia; 1997 Oct; 40(10):1141-51. PubMed ID: 9349594
[TBL] [Abstract][Full Text] [Related]
7. Chronic Running Exercise Alleviates Early Progression of Nephropathy with Upregulation of Nitric Oxide Synthases and Suppression of Glycation in Zucker Diabetic Rats.
Ito D; Cao P; Kakihana T; Sato E; Suda C; Muroya Y; Ogawa Y; Hu G; Ishii T; Ito O; Kohzuki M; Kiyomoto H
PLoS One; 2015; 10(9):e0138037. PubMed ID: 26379244
[TBL] [Abstract][Full Text] [Related]
8. Angelica acutiloba root alleviates advanced glycation end-product-mediated renal injury in streptozotocin-diabetic rats.
Liu IM; Tzeng TF; Liou SS; Chang CJ
J Food Sci; 2011 Sep; 76(7):H165-74. PubMed ID: 22417553
[TBL] [Abstract][Full Text] [Related]
9. From molecular footprints of disease to new therapeutic interventions in diabetic nephropathy.
Miyata T; Yamamoto M; Izuhara Y
Ann N Y Acad Sci; 2005 Jun; 1043():740-9. PubMed ID: 16037301
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM
Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
[TBL] [Abstract][Full Text] [Related]
11. A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.
Schrijvers BF; Flyvbjerg A; Tilton RG; Lameire NH; De Vriese AS
Nephrol Dial Transplant; 2006 Feb; 21(2):324-9. PubMed ID: 16249198
[TBL] [Abstract][Full Text] [Related]
12. Increase of anti-oxidation by exercise in the liver of obese Zucker rats.
Chang SP; Chen YH; Chang WC; Liu IM; Cheng JT
Clin Exp Pharmacol Physiol; 2004 Aug; 31(8):506-11. PubMed ID: 15298542
[TBL] [Abstract][Full Text] [Related]
13. Increased renal collagen cross-linking and lipid accumulation in nephropathy of Zucker diabetic fatty rats.
Li Y; Qi Y; Kim MS; Xu KZ; Huang TH; Rong X; Murray M; Yamahara J
Diabetes Metab Res Rev; 2008 Sep; 24(6):498-506. PubMed ID: 18613221
[TBL] [Abstract][Full Text] [Related]
14. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription.
Liu IM; Tzeng TF; Liou SS; Chang CJ
J Ethnopharmacol; 2009 Jul; 124(2):211-8. PubMed ID: 19397971
[TBL] [Abstract][Full Text] [Related]
15. Merit of physical exercise to reverse the higher gene expression of hepatic phosphoenolpyruvate carboxykinase in obese Zucker rats.
Chang SP; Chen YH; Chang WC; Liu IM; Cheng JT
Life Sci; 2006 Jun; 79(3):240-6. PubMed ID: 16458327
[TBL] [Abstract][Full Text] [Related]
16. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.
Ninichuk V; Kulkarni O; Clauss S; Anders H-
Eur J Med Res; 2007 Aug; 12(8):351-5. PubMed ID: 17933712
[TBL] [Abstract][Full Text] [Related]
17. Effects of magnolol (5,5'-diallyl-2,2'-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats.
Sohn EJ; Kim CS; Kim YS; Jung DH; Jang DS; Lee YM; Kim JS
Life Sci; 2007 Jan; 80(5):468-75. PubMed ID: 17070554
[TBL] [Abstract][Full Text] [Related]
18. A novel Sartan derivative with very low angiotensin II type 1 receptor affinity protects the kidney in type 2 diabetic rats.
Izuhara Y; Sada T; Yanagisawa H; Koike H; Ohtomo S; Dan T; Ito S; Nangaku M; van Ypersele de Strihou C; Miyata T
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1767-73. PubMed ID: 18658044
[TBL] [Abstract][Full Text] [Related]
19. Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice.
Tanimoto M; Gohda T; Kaneko S; Hagiwara S; Murakoshi M; Aoki T; Yamada K; Ito T; Matsumoto M; Horikoshi S; Tomino Y
Metabolism; 2007 Feb; 56(2):160-7. PubMed ID: 17224327
[TBL] [Abstract][Full Text] [Related]
20. XLF-III-43, a novel coumarin-aspirin compound, prevents diabetic nephropathy in rats via inhibiting advanced glycation end products.
Li H; Zheng X; Wang H; Zhang Y; Xin H; Chen X
Eur J Pharmacol; 2010 Feb; 627(1-3):340-7. PubMed ID: 19895808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
